Related Experiment Videos
Anthrax lethal toxin blocks MAPK kinase-dependent IL-2 production in CD4+ T cells
Hui Fang1, Ruth Cordoba-Rodriguez, Carla S R Lankford
1Division of Monoclonal Antibodies, Office of Biotechnology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Bethesda, MD 20892, USA.
Journal of Immunology (Baltimore, Md. : 1950)
|April 9, 2005
Summary
Anthrax lethal toxin (LT) inactivates crucial signaling proteins in human T cells, inhibiting their proliferation and IL-2 production. This discovery enables new human cell-based assays for LT activity and reveals immune evasion strategies.
Area of Science:
- Immunology
- Molecular Biology
- Microbial Pathogenesis
Background:
- Anthrax lethal toxin (LT) is a key virulence factor targeting host cell signaling.
- Current anthrax LT assays lack human cell relevance.
- LT's effect on human T cell function is not well understood.
Purpose of the Study:
- To investigate the impact of anthrax LT on human T cell function.
- To establish human cell-based assays for anthrax LT activity.
- To elucidate mechanisms of immune evasion by Bacillus anthracis.
Main Methods:
- Utilized Jurkat T cell line and primary human CD4+ T cells.
- Assessed MAPKK cleavage and T cell signaling pathways.
- Measured IL-2 production and T cell proliferation.
- Employed a protease inhibitor to block LT activity.
Main Results:
- Anthrax LT specifically cleaves and inactivates MAPKKs in Jurkat and primary CD4+ T cells.
- LT inhibits IL-2 production and proliferation in response to T cell receptor stimulation.
- Protease inhibition fully restored IL-2 production.
- LT caused a 95% reduction in anti-CD3-induced T cell responses.
Conclusions:
- Anthrax LT directly impairs human T cell function, crucial for immune response regulation.
- These findings support the development of novel human cell-based bioassays for LT.
- LT's inhibition of T cell responses represents a significant immune evasion mechanism for Bacillus anthracis.